GO
Loading...

Science

More

  • Ebola patient Writebol arrives in Atlanta  Tuesday, 5 Aug 2014 | 1:19 PM ET

    The second American with Ebola has arrived in Atlanta, reports CNBC's Sue Herera.

  • Germ-zapping robot on 'Power Lunch'  Tuesday, 5 Aug 2014 | 1:19 PM ET

    Xenex Disinfection Services hopes to fight the war against Ebola. Its CEO Morris Miller shares a demonstration of the company's disinfection robot Sara, which he claims can destroy a deadly virus in 5-10 minutes.

  • Battle for experimental drugs  Tuesday, 5 Aug 2014 | 11:26 AM ET

    CNBC's Meg Tirrell explains how patients with serious diseases, who have exhausted hope from medicines on the market, turn to compassionate use campaigns.

  • Ebola patient Writebol expected in Atlanta today  Tuesday, 5 Aug 2014 | 10:09 AM ET

    NBC's Jay Gray reports Ebola patient Nancy Writebol will arrive at Emory Hospital in Atlanta today.

  • Battling a rare cancer: Nathalie's story  Tuesday, 5 Aug 2014 | 7:30 AM ET

    Nathalie Traller, a 15-year-old cancer patient, talks about the challenges of getting access to experimental treatments for a rare form of the disease.

  • Treating Nathalie Traller's cancer  Tuesday, 5 Aug 2014 | 7:30 AM ET

    Nathalie Traller has a rare cancer, but at 15 years old, it's been difficult to get access to treatments.

  • CNBC's Bertha Coombs reports a patient with a high fever and gastrointestinal symptoms is undergoing screenings to determine cause of symptoms at Mt. Sinai hospital.

  • The Ebola threat  Monday, 4 Aug 2014 | 2:01 PM ET
    Gloves and boots used by medical staff drying in the sun at a center for Ebola victims in Guinea.

    Ebola is now in 4 countries. NBC News' Sarah Daloff reports Emory Hospital in Atlanta, Georgia, is preparing for the arrival of the second Ebola patient Nancy Writebol.

  • Bionic eyes to supercomputers: Inside Livermore Thursday, 31 Jul 2014 | 4:32 PM ET
    Jeff Wisoff in front of the world’s largest laser at the Lawrence Livermore National Laboratory.

    Lawrence Livermore is reaching out to private industry amid a race for talent and ideas to solve pressing issues including national security.

  • AIDS researchers reported on MH17  Friday, 18 Jul 2014 | 1:23 PM ET

    Reports say there could have been 100 AIDS researchers and advocates on the Malaysia Airlines flight which was shot down in Ukraine, with CNBC's Meg Tirrell.

  • Close look at traders' brain activity  Friday, 11 Jul 2014 | 2:41 PM ET

    Neuroscientist Read Montague performed a study of traders' brain activity while trading. He shares which traders made the most money in the experiment.

  • Climate skeptics look to prove their skeptics wrong Monday, 7 Jul 2014 | 8:00 AM ET
    Mana Pools National Park. Zimbabwe

    Climate change skeptic group The Heartland Institute hosts its annual conference this week and hopes to take on President Obama and others.

  • Cool pharma tech  Tuesday, 10 Jun 2014 | 5:27 PM ET

    CNBC's Meg Tirrell reports which pharmaceutical stocks are ready for the future of medicine, including Covidien's swallowable pill-size camera.

  • Rethinking health care  Tuesday, 10 Jun 2014 | 2:53 PM ET

    Why does the U.S. spend so much money on health care? Daniel Kraft, Exponential Medicine executive director, says the U.S. spends a lot of money on "sick" care, not health care, and provides insight to new technology developments in the industry.

  • Immunotherapies hit ASCO  Thursday, 29 May 2014 | 3:35 PM ET

    This year's biggest cancer conference begins tomorrow. CNBC's Meg Tirrell reports why immunotherapy drugs will be a key theme with drug makers at ASCO.

  • War on cancer  Thursday, 29 May 2014 | 1:38 PM ET

    The big topic at this year's cancer care conference ASCO will be immunotherapy drugs. CNBC's Meg Tirrell explains how these drugs work.

  • Second case of MERS in US  Monday, 12 May 2014 | 2:28 PM ET

    CNBC's Meg Tirrell reports the Center for Disease Control has confirmed the second case of MERS has been identified in the U.S.

  • Ethics of 'right to try' laws  Tuesday, 6 May 2014 | 2:35 PM ET

    Lawmakers in four states are considering changing the rules to allow terminally ill people access to experimental drugs before they have FDA approval. Kenneth Goodman, University of Miami, thinks this would be a bad bet for patients. Miles Nadal, MDC Partners Chairman & CEO, weighs in.

  • Pharma deal of the day  Tuesday, 6 May 2014 | 12:27 PM ET

    CNBC's Meg Tirrell spoke with Merck Chairman & CEO Ken Frazier about the company's decision to sell its over the counter health care products to Bayer.

  • 'Super bug' spreads  Monday, 5 May 2014 | 1:32 PM ET

    CNBC's Meg Tirrell reports the World Health Organization has confirmed about 262 cases of the MERS virus, of which 93 people have died. Dr. William Schaffner of the Vanderbilt School of Medicine, provides insight.